CAS 242478-38-2
:Solifenacin succinate
Description:
Solifenacin succinate is a pharmaceutical compound primarily used as an antimuscarinic agent for the treatment of overactive bladder. It functions by selectively inhibiting the M3 muscarinic receptors in the bladder, leading to reduced detrusor muscle contractions and increased bladder capacity. This compound is characterized by its high selectivity for the M3 receptor, which minimizes side effects commonly associated with anticholinergic medications. Solifenacin succinate is typically administered orally and is known for its favorable pharmacokinetic profile, including good absorption and a relatively long half-life, allowing for once-daily dosing. The substance is a white to off-white crystalline powder, soluble in water and various organic solvents. Its chemical structure includes a succinate moiety, which contributes to its pharmacological properties. As with many medications, potential side effects may include dry mouth, constipation, and urinary retention, necessitating careful patient monitoring. Overall, Solifenacin succinate represents an important therapeutic option for managing symptoms of overactive bladder.
Formula:C23H26N2O2·C4H6O4
InChI:InChI=1S/C23H26N2O2.C4H6O4/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19;5-3(6)1-2-4(7)8/h1-9,18,21-22H,10-16H2;1-2H2,(H,5,6)(H,7,8)/t21-,22-;/m0./s1
InChI key:InChIKey=RXZMMZZRUPYENV-VROPFNGYSA-N
SMILES:C(O[C@@H]1C2CCN(C1)CC2)(=O)N3[C@H](C=4C(CC3)=CC=CC4)C5=CC=CC=C5.C(CC(O)=O)C(O)=O
Synonyms:- (3R)-1-azabicyclo[2.2.2]oct-3-yl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate butanedioate (1:1)
- 1-Azabicyclo[2.2.2]octan-8-yl (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate butanedioic acid
- 1-azabicyclo[2.2.2]oct-3-yl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate
- 1-azabicyclo[2.2.2]oct-3-yl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate butanedioate (1:1)
- 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester, (1S)-, butanedioate (1:1)
- Butanedioic acid, compd. with (1S)-(3R)-1-azabicyclo[2.2.2]oct-3-yl 3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate (1:1)
- Vesicare
- Vesikur
- Ym 67905
- Solifenacin succinate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 17 products.
Solifenacin Succinate
CAS:Formula:C23H26N2O2·C4H6O4Purity:>98.0%(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:480.56Solifenacin succinate impurity standard
CAS:Solifenacin succinate impurity standardColor and Shape:WhiteSOLIFENACIN FOR SYSTEM SUITABILITY CRS
CAS:<p>SOLIFENACIN FOR SYSTEM SUITABILITY CRS</p>Formula:C27H32N2O6Color and Shape:PowderMolecular weight:480.5528SOLIFENACIN SUCCINATE CRS
CAS:<p>SOLIFENACIN SUCCINATE CRS</p>Formula:C27H32N2O6Color and Shape:PowderMolecular weight:480.5528Solifenacin succinate
CAS:Solifenacin succinateFormula:C27H32N2O6Purity:99.8%Color and Shape:WhiteMolecular weight:480.22604Solifenacin Succinate
CAS:<p>Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticides</p>Formula:C23H26N2O2·C4H6O4Color and Shape:White Off-White PowderMolecular weight:480.226041-Azabicyclo[2.2.2]octan-8-yl (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate butanedioic acid
CAS:Formula:C27H32N2O6Purity:98%Color and Shape:SolidMolecular weight:480.5528Solifenacin succinate
CAS:<p>Solifenacin succinate (YM905) is a quinuclidine and tetrahydroisoquinoline derivative and selective M3 muscarinic antagonist, which is used as a urologic agent.</p>Formula:C23H26N2O2·C4H6O4Purity:99.85% - 99.98%Color and Shape:SolidMolecular weight:480.56Solifenacin Succinate
CAS:Formula:C23H26N2O2·C4H6O4Color and Shape:White To Off-White SolidMolecular weight:362.47 118.09Solifenacin Succinate
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Muscarinic M3 receptor antagoinst. Used in treatment of urinary incontinence.<br>References Ikeda K., et al.: Arch. Pharmacol., 366, 97, (2002), Chapple, C.R., et al.: Br. J. Urol., 93, 303 (2004), Ohtake, A., et al.: Eur. J. Pharmacol., 492, 243 (2004), Brunton, S., et al.: Curr. Med. Res. Opin., 21, 71 (2005), Habb, F., et al.: Eur. Urol. 47, 376 (2005), Payne, C.K., et al.: Drugs, 66, 175 (2006),<br></p>Formula:C23H26N2O2·C4H6O4Color and Shape:WhiteMolecular weight:480.55Solifenacin succinate
CAS:<p>Muscarinic receptor antagonist</p>Formula:C23H26N2O2•C4H6O4Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:480.55 g/molSolifenacin succinate - Bio-X ™
CAS:<p>Solifenacin is a muscarinic antagonist drug that is used to treat symptoms associated with an overactive bladder such as urine urgency and urinary incontinence. This drug has high affinity for M1, M2 and M3 receptors, with its highest being for M3 receptors. Antagonism of these receptors prevent contraction of smooth muscles in the bladder.</p>Formula:C23H26N2O2·C4H6O4Purity:Min. 95%Color and Shape:PowderMolecular weight:480.55 g/mol












